Telomerase activity in Hodgkin's disease

Blood

Volumn 92, Issue 2, 1998, Pages 567-573

  Norrback, Karl Fredrik ^a   Enblad, Gunilla ^a   Erlanson, Martin ^b   Sundström, Christer ^a   Roos, Göran ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CELL IMMORTALIZATION; CORRELATION FUNCTION; ENZYME ACTIVITY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REED STERNBERG CELL; TARGET CELL;

EID: 0032528448     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.2.567.414a18_567_573     Document Type: Article

References (40)

1. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu J-R: A highly conserved repetitive DNA sequence, (TTAGGG), present at the telomeres of human chromosomes. Proc Natl Acad Sei USA 85:6622, 1988
2. Blackburn EH: Structure and function of telomeres. Nature 350:569, 1991
3. Wright WE, Shay JW: Telomefe positional effects and the regulation of cellular senescence. Trends Genet 8:193, 1992
4. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB: Telomere end-replication problem and cell aging. J Mol Biol 225:951, 1992
5. Allsopp RC, Harley CB: Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219:130, 1995
6. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutât Res 256:271, 1991
7. Bryan TM, Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33:767, 1997
8. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33:787, 1997
9. Norrback K-F, Roos G: Telomeres and telomerase in normal and malignant haematopoietic cells. Eur J Cancer 33:774, 1997
10. Leber B, Bacchetti S: Telomeres and telomerase in normal and malignant haematologic cells. Leuk Lymphoma 24:1, 1996
11. Igarashi H, Sakaguchi N: Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89:1299, 1997
12. Norrback K-F, Dahlenborg K, Carlsson R, Roos G: Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88:222, 1996
13. Greaves M: Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 12:127, 1996
14. Shay JW, Wright WE: The reactivation of telomerase activity in cancer progression. Trends Genet 12:129, 1996
15. Poppema S, Kaleta J, Hepperle B, Visser L: Biology of Hodgkin's disease. Ann Oncol 3:5, 1992
16. Inghirami G, Macri L, Rosati S, Zhu BY, Yee HT, Knowles DM: The Reed-Sternberg cells of Hodgkin disease are clonal. Proc Natl Acad Sei USA 91:9842, 1994
17. Sabattini E, Gerdes J, Gherlinzoni F, Poggi S, Zucchini L, Melilli G, Grigioni F, del Vecchio MT, Leoncini L, Falini B, Pileri SA: Comparison between the monoclonal antibodies Ki-67 and PC 10 in 125 malignant lymphomas. J Pathol 169:397, 1993
18. Brousset P, Saati TA, Chaouche N, Zenou RC, Schlaifer D, Chittal S, Dclsol G: Telomerase activity in reactive and neoplastic lymphoid tissues: Infrequent detection of activity in Hodgkin's disease. Blood 89:26, 1997
19. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checke! JL, Kita H, Thomas LL, Gleich GJ: Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 52:611, 1992
20. Vindelov L, Christensen U, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323, 1983
21. Hansel TT, de Vries UM, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C: An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 145:105, 1991
22. Peterson CGB, Venge P: Purification and characterization of a new cationic protein, eosinophil protein-X (EPX), from granules of human eosinophils. Immunology 50:19, 1983
23. Peterson CGB, Jörnvall H, Venge P: Purification and characterization of eosinophil cationic protein from normal human eosinophils. EurJHaematol40:415, 1988
24. Enblad G, Sundström C, Glimelius B: Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 11:187, 1993
25. Enblad G, Amini R-M, Sundström C, Glimelius B: Serum levels of soluble CD 30 and their relationship to tumour burden and prognosis in patients with Hodgkin's disease. Haematology (in press)
26. Piatyszek MA, Kirn NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sei 17:1, 1995
27. Wright WE, Shay JW, Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23:3794, 1995
28. Holt SE, Norton JC, Wright WE, Shay JW: Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sei 18:237, 1996
29. Slifman NR, Loegering DA, McKean DJ, Gleich GJ: Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 137:2913, 1986
30. Blackburn P, Wilson G, Moore S: Ribonuclease inhibitor from human placenta. J Biol Chem 252:5904, 1977
31. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. LeukLymphoma9:l, 1992
32. Olsson I, Venge P: Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 44:235, 1974
33. Rosenberg HF, Tenen DG, Ackerman SJ: Molecular cloning of the human eosinophil-derived neurotoxin: A member of the ribonuclease gene family. Proc Natl Acad Sei USA 86:4460, 1989
34. Sorrentino S, Glitz DG, Hamann KJ, Loegering DA, Checkel JL, Gleich GJ: Eosinophil-derived Neurotoxin and human liver ribonuclease.JBiolChem 267:14859, 1992
35. Beintema JJ, Hofsteenge J, Iwama M, Monta T, Ohgi K, trie M, Sugiyama RH, Schieven GL, Dekker CA, Glitz DG: Amino acid sequence of the nonsecretory ribonuclease of human urine. Biochemistry 27:4530, 1988
36. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87:895, 1995
37. Holt SE, Wright WE, Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16:2932, 1996
38. Sharma HW, Sokoloski JA, Ferez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sei USA 92:12343, 1995
39. Haluska FG, Brufsky AM, Canellos GP: The cellular biology of the Reed-Sternberg cell. Blood 84:1005, 1994
40. Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, Gazdar AF: Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 50:110, 1997